Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Clinical Trials in Duarte, California

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma